U.S., April 11 -- ClinicalTrials.gov registry received information related to the study (NCT06921980) titled 'Brain Function and Psychological Changes Related to Cell Therapy for Autoimmune Hemolytic Anemia' on April 02.
Brief Summary: Cell therapy is an innovative treatment with significant efficacy in hematologic and certain autoimmune diseases. Although it offers potential benefits for autoimmune hemolytic anemia (AIHA), it may result in cognitive and other potential impairments, which can adversely affect patients' cognition and behavior.
Brain function and psychological assessment are essential for the early detection of potential impairments, allowing timely interventions to prevent complications and ensure patient safety. This stud...